IDBI Healthcare Fund - Dividend - Direct Plan

  • Previous Nav

  • Net Change on 24-01-2020

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Dividend | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
S&P BSE Health Care - TRI 5.36 9.72 1.05 -0.87 -1.29 12.01

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund - Direct Plan Dividend Plan Jan 01, 2013 2.94 6.69 4.67 1.36 2,416.99
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -DIVIDEND Jan 01, 2013 2.33 -0.79 1.03 1.31 926.47
UTI Healthcare Fund -Direct Plan - Income Option Jan 01, 2013 5.00 1.99 0.89 1.76 394.61

Fund Holdings as on 31-December-2019

  • Sun Pharmaceutical Industries Ltd.

  • Divi's Laboratories Ltd.

  • Cipla Ltd.

  • TREPS

  • Lupin Ltd.

  • Sanofi India Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • IPCA Laboratories Ltd.

  • Pfizer Ltd.

  • Aurobindo Pharma Ltd.

  • Natco Pharma Ltd.

  • Abbott India Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Alkem Laboratories Ltd.

  • Dr. Lal Path labs Ltd.

  • Syngene International Ltd.

  • Alembic Pharmaceuticals Ltd.

  • Biocon Ltd.

  • ICICI Lombard General Insurance Company Ltd.

  • AstraZeneca Pharma India Ltd.

  • Cadila Healthcare Ltd.

  • Aarti Industries Ltd.

  • Procter & Gamble Hygiene and Health Care Ltd.

  • Net Receivable / Payable

View More
  • Pharmaceuticals & Drugs

  • Miscellaneous

  • Hospital & Healthcare Services

  • Insurance

  • Chemicals

  • Household & Personal Products

View More

About IDBI Healthcare Fund

Scheme Analysis

IDBI Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to IDBI Mutual Fund. It was launched on 28-Feb-2019 and currently has an AUM of ₹31.32 crore. IDBI Healthcare Fund is benchmarked against S&P BSE Health Care - TRI as primary index.

The NAV of IDBI Healthcare Fund ended up ₹0.03(0.27%)yesterday to ₹11.09.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The IDBI Healthcare Fund is managed by Uma Venkatraman .

Fund House Contact

5th floor, Mafatlal Centre, Nariman Point Mumbai - 400021

022-6644 2800
022-6644 2802

Fund Manager

  • Cash

  • Equity

View More